1 Introduction to Global Recombinant Coagulation Factors Market
1.1 Global Recombinant Coagulation Factors Market Ecosystem
1.1.1 Recombinant Coagulation Factors Market Types
1.1.2 Recombinant Coagulation Factors Market hemophilia type
1.1.3 Recombinant Coagulation Factors Market End-users
1.2 Report Elucidation
1.3 Market Buzz and Foreground
1.4 Research Methodology
2 Executive Summary
3 Market Insights
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Market Share Analysis
3.5 Recombinant Coagulation Factors Pipeline Analysis
4 Global Recombinant Coagulation Factors- Market Crackdown ($ Value Analysis), By Type
4.1 Recombinant Factor VIII
4.2 Recombinant Factor IX
4.3 VonWillebrandFractor
5 Global Recombinant Coagulation Factors- Market Crackdown ($ Value Analysis), by hemophilia type
5.1 Hemophilia A
5.2 Hemophilia B
6 Global Recombinant Coagulation Factors- Market Crackdown ($ Value Analysis), by End user
6.1 Hospitals
6.2 Research Organization
6.3 Academic Institutes
7 Recombinant Coagulation Factors – Market Crackdown ($ Value Analysis, by Geography
7.1 North America
7.1.1.1 U.S.
7.1.1.2 Canada
7.1.2 Europe
7.1.2.1 U.K.
7.1.2.2 France
7.1.2.3 Germany
7.1.2.4 Italy
7.1.2.5 Spain
7.1.2.6 Rest of Europe
7.1.3 Asia-Pacific
7.1.3.1 China
7.1.3.2 Japan
7.1.3.3 India
7.1.3.4 Rest of Asia-Pacific
7.1.4 RoW
7.1.4.1 Latin America
7.1.4.2 Africa
7.1.4.3 Middle East
8 Global Recombinant Coagulation Factors Market- Competitive Landscape
8.1 Agreements, Collaborations, Partnerships, and Joint Ventures
8.2 Expansions
8.3 Mergers & Acquisitions
8.4 New Product Launches
8.5 Other Developments
9 Company Profiles
9.1 Baxter International Inc
9.1.1 Company Overview
9.1.2 Financials
9.1.3 Products & Services
9.1.4 Recent Developments
9.2 Grifols International SA
9.2.1 Company Overview
9.2.2 Financials
9.2.3 Products & Services
9.2.4 Recent Developments
9.3 CSL Ltd.
9.3.1 Company Overview
9.3.2 Financials
9.3.3 Products & Services
9.3.4 Recent Developments
9.4 Octapharma AG
9.4.1 Company Overview
9.4.2 Financials
9.4.3 Products & Services
9.4.4 Recent Developments
9.5 Kedrion S.P.A.
9.5.1 Company Overview
9.5.2 Financials
9.5.3 Products & Services
9.5.4 Recent Developments
9.6 Novo Nordisk A/S
9.6.1 Company Overview
9.6.2 Financials
9.6.3 Products & Services
9.6.4 Recent Developments
9.7 Pfizer Inc
9.7.1 Company Overview
9.7.2 Financials
9.7.3 Products & Services
9.7.4 Recent Developments
9.8 Bayer AG
9.8.1 Company Overview
9.8.2 Financials
9.8.3 Products & Services
9.8.4 Recent Developments
9.9 Biogen Idec
9.9.1 Company Overview
9.9.2 Financials
9.9.3 Products & Services
9.9.4 Recent Developments
List of Tables
Table 1 Global Recombinant Coagulation Factor Market Size, By Product,Through 2020 ($Million)
Table 2 Global Recombinant Coagulation Factor Market Size, By Geography, Through 2020 ($Million)
Table 3 Global Recombinant Factor VIII Market Size, By Country/Region, Through 2020 ($Million)
Table 4 Global Recombinant Factor IX Market Size, By Country/Region, Through 2020 ($Million)
Table 5 Global Von Willebrand factor Market Size, By Country/Region, Through 2020 ($Million)
Table 6 Global Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 7 Global Recombinant Coagulation Factor Market Size, By Geography, Through 2020 ($Million)
Table 8 Global Recombinant Coagulation Factor Market Size, For Hemophilia A, Through 2020 ($Million)
Table 9 Global Recombinant Coagulation Factor Market Size, For Hemophilia B, Through 2020 ($Million)
Table 10 Global Recombinant Coagulation Factor Market Size, By end-user, Through 2020 ($Million)
Table 11 Global Recombinant Coagulation Factor For Hospitals And Clinics, By Country/Region, Through 2020 ($Million) )
Table 12 Global Recombinant Coagulation Factor For Research Organizations, By Country/Region, Through 2020 ($Million)
Table 13 Global Recombinant Coagulation Factor For Academic Institutes, By Country/Region, Through 2020 ($Million)
Table 14 North America: Recombinant Coagulation Factor Market Size, By Country, Through 2020 ($Million)
Table 15 North America: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 16 North America: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 17 North America: Recombinant Coagulation Factor Market, By End User, Through 2020 ($Million)
Table 18 U.S.: Plasma Fractionation Market Size, By Products, Through 2020 ($Million)
Table 19 U.S.: Recombinant Coagulation Factor Market Size, By Product, Through 2020 ($Million)
Table 20 U.S.: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 21 U.S.: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 22 Canada: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 23 Canada: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 24 Canada: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 25 Europe: Recombinant Coagulation Factor Market Size, By Country/Region, Through 2020 ($Million)
Table 26 Europe: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 27 Europe: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 28 Europe: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 29 Germany: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 30 Germany: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 31 Germany: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 32 U.K.: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 33 U.K.: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 34 U.K.: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 35 France: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 36 France: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 37 France: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 38 Italy: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 39 Italy: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 40 Italy: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 41 Spain: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 42 Spain: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 43 Spain: Recombinant Coagulation Factor Market Size, By End Users, 2015-2020 ($Million)
Table 44 ROE: Recombinant Coagulation Factor Market Size, By Products, 2015-2020 ($Million)
Table 45 ROE: Recombinant Coagulation Factor Market Size, By Hemophilia Type , 2015-2020 ($Million)
Table 46 ROE: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 47 Asia-Pacific: Recombinant Coagulation Factor Market Size, By Country/Region, Through 2020 ($Million)
Table 48 Asia-Pacific: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 49 Asia-Pacific: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 50 Asia-Pacific: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 51 Japan: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 52 Japan: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 53 Japan: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 54 China: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 55 China: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 56 China: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 57 India: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 58 India: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 59 India: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 60 Rest Of Asia-Pacific: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 61 Rest Of Asia-Pacific: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 62 Rest Of Asia-Pacific: Recombinant Coagulation Factor Market Size, By End User,Through 2020 ($Million)
Table 63 ROW: Recombinant Coagulation Factor Market Size, By Country/Region, 2015-2020 ($Million)
Table 64 ROW: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 65 ROW: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 66 ROW: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 67 Latin America: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 68 Latin America: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 69 Latin America: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 70 Middle East & Africa: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 71 Middle East & Africa: Recombinant Coagulation Factor Market Size, By Hemophilia Type,Through 2020 ($Million)
Table 72 Middle East & Africa: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 72 New Product Launches, 2012–2015
Table 73 Expansions, 2012–2015
Table 74 Mergers And Acquisitions, 2012–2015
Table 75 Agreements, Partnerships, Collaborations, And Joint Ventures, 2012–2015
List of Figures
Figure 1 Recombinant Coagulation Factor VIII will dominate the market
Figure 2 Hemophilia A will dominate the Global Recombinant Coagulation Market
Figure 3 Hospital and Clinics will dominate the Global Recombinant Coagulation Market
Figure 4 Baxter International Inc.: Financial Detail
Figure 5 Octapharma AG: Financial Detail
Figure 6 Bayer AG: Financial Detail
Figure 7 CSL Ltd.: Financial Detail
Figure 8 Grifols International SA: Financial Detail
Figure 9 Kedrion S.P.A.: Financial Detail
Figure 10 Novo Nordisk A/S: Financial Detail
Figure 12 Biogen Idec: Financial Detail
Figure 13 Pfizer Inc. : Financial Detail
